News TagCloud
- Agreement
- Auris
- BioValley
- Board
- Drug
- EBIT
- European
- Genzyme
- Half
- Lonza
- Management
- Manufacturing
- Medical
- Novartis
- Novozymes
- Performance
- Phase
- QIAGEN
- Quarter
- RARE
- Results
- Roche
- Round
- Siegfried
- Straumann
- Syna
- Syngenta
- Third
- Unia
- announces
- commercial
- data
- disease
- growth
- holding
- million
- mondoBIOTECH
- named
- patients
- positive
- reporting
- reports
- research
- results
- revenues
- rights
- show
- significantly
- stable
- treatment
BioValley News
Teva and Cephalon Receive FTC Request for Additional Information
Jerusalem, Israel and Frazer, PA - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Cephalon, Inc. (NASDAQ: CEPH) announced that, as expected, each party has received a request for additional information (commonly referred...[more]
Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients with Chronic Kidney Disease and Type 2 Diabetes
Irving, Texas, and Abbott Park, Illinois - Reata Pharmaceuticals, Inc. and Abbott announced the initiation of a pivotal Phase 3 clinical trial to evaluate the safety and efficacy of bardoxolone methyl in patients with chronic...[more]
Bayer foundation scholarships – EUR 200,000 for work and study abroad
Leverkusen - Applications for the scholarship programs of the Bayer Science & Education Foundation can now be submitted once again. In the academic sector, ambitious students can apply for a Bayer, Carl Duisberg or Kurt Hansen...[more]
Acino signs commercial manufacturing contract with Bayer
Basel - Acino and Bayer HealthCare Pharmaceuticals have signed a multi-year, exclusive manufacturing contract on Bayer’s novel contracep-tive patch.[more]
Sanofi Enters into Research Collaboration with Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
Paris, France - June 16, 2011 - Sanofi (EURONEXT: SAN and NYSE: SNY) announced that it has entered into a two-year research collaboration with the biopharmaceutical company Audion Therapeutics (Audion) to develop potential...[more]
Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia
Basel - Novartis today held a groundbreaking ceremony to announce the start of construction of a pharmaceutical manufacturing plant in St. Petersburg, Russia.[more]
Johnson & Johnson Announces Special Charge Related to Restructuring Plans for Cordis Corporation Subsidiary
NEW BRUNSWICK, N.J. - Johnson & Johnson (NYSE: JNJ) announced that it expects to record an after-tax restructuring charge in the range of $500-$600 million in the second quarter of 2011 as a result of restructuring plans...[more]
GE Centricity Enterprise 6.9 Achieves 2011/2012 Ambulatory Certification
BARRINGTON, Ill. - GE Healthcare is pleased to announce that GE Centricity Enterprise 6.9 was certified as a Complete Ambulatory-EHR for 2011/2012 on June 9, 2011 by Drummond Group Inc.[more]
Ethicon Endo-Surgery Introduces Innovative New Generator to Help Simplify Use of Advanced Energy Technology in the OR
Cincinnati, OH - In an effort to help simplify the OR, Ethicon Endo-Surgery, Inc. (EES) announces U.S. FDA 510(k) clearance and the launch of the first ever Advanced Energy Generator made to power both ultrasonic and advance...[more]
GE Healthcare’s Gemstone Spectral Imaging Emerging as a “Must Have” Diagnostic Tool
WAUKESHA, WISCONSIN - Affirming its commitment to high quality patient care, GE Healthcare spotlighted the increased clinical adoption and emergence as a ”must have” tool of its Gemstone Spectral Imaging* (GSI) Computed...[more]
News Categories
News Archive
Contact Form
Leonhard E. Loew
BioValley Basel Association
Aeschenvorstadt 57
CH-4051 Basel / Switzerland
Tel. +41 61 271 59 30
info(at)biovalley.ch
